Trials / Unknown
UnknownNCT03800095
Early Palliative Care for Patients With Haematological Malignancies
Early Palliative Care for Patients With Haematological Malignancies: A Randomised Prospective Study
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 140 (estimated)
- Sponsor
- University Hospital, Clermont-Ferrand · Academic / Other
- Sex
- All
- Age
- 70 Years
- Healthy volunteers
- Not accepted
Summary
Patients suffering from haematological disease present symptoms of discomfort and currently benefit from palliative care skills only for the management of their end-of-life. However, in medical oncology, more and more studies tend to demonstrate the benefit on the quality of life of an early collaboration between the two specialties. Investigator did the hypothesis that early integration of palliative care with conventional haematological care could decrease discomfort symptoms and add a real benefit on the patients' quality of life .
Detailed description
Patients suffering from haematological disease present symptoms of discomfort and currently benefit from palliative care skills only for the management of their end-of-life. However, in medical oncology, more and more studies tend to demonstrate the benefit on the quality of life of an early collaboration between the two specialties. Investigator did the hypothesis that early integration of palliative care with conventional haematological care could decrease discomfort symptoms and add a real benefit on the patients' quality of life .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Early palliative care integration | The follow-up time for each patient is 12 months with evaluation of the main objective by a standardized questionnaire: The Functional Assessment of Cancer Therapy-Anaemia (FACT-An) Scale at 6 months. Throughout the study, patients included will receive conventional haematological care and the interventional arm will benefit in addition to a monthly consultation by a palliative care team. |
Timeline
- Start date
- 2019-03-14
- Primary completion
- 2023-08-14
- Completion
- 2023-12-31
- First posted
- 2019-01-11
- Last updated
- 2021-03-24
Locations
6 sites across 1 country: France
Source: ClinicalTrials.gov record NCT03800095. Inclusion in this directory is not an endorsement.